Rock Springs Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Rock Springs Capital Management’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,174,786	Closed	-$64.6M	–	133
2022 Q2	$64.6M	Hold	1,174,786	–	–	1.88%	13
2022 Q1	$37.7M	Sell	1,174,786 -10,007	-0.8%	-$287K	0.95%	36
2021 Q4	$25.8M	Sell	1,184,793 -129,204	-10%	-$2.85M	0.6%	54
2021 Q3	$28.8M	Buy	1,313,997 +295,339	+29%	+$5.91M	0.61%	54
2021 Q2	$19.8M	Buy	1,018,658 +1,300	+0.1%	+$23.6K	0.39%	76
2021 Q1	$17.5M	Buy	1,017,358 +450,000	+79%	+$7.13M	0.38%	77
2020 Q4	$9.1M	Buy	+567,358	New	+$7.88M	0.19%	116

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Rock Springs Capital Management's SRRA Position: Q3 2022 in Review

Rock Springs Capital Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 1,174,786 shares — an estimated $64.6M sold.

Rock Springs Capital Management first reported a position in SRRA in Q4 2020 and held it in 7 quarters. The position peaked at $64.6M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

Rock Springs Capital Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Rock Springs Capital Management sold 1,174,786 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $64.6M.
Rock Springs Capital Management first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Rock Springs Capital Management's Sierra Oncology, Inc. Common Stock position peaked at $64.6M in Q2 2022.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Rock Springs Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.